Early Epirubicin-Induced Myocardial Dysfunction Revealed by Serial Tissue Doppler Echocardiography: Correlation with Inflammatory and Oxidative Stress Markers
Author:
Affiliation:
1. a Department of Cardiovascular and Neurological Sciences, Cagliari, Italy
2. b Medical Oncology, University of Cagliari, Cagliari, Italy
Abstract
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-9-1124
Reference46 articles.
1. The natural history of idiopathic dilated cardiomyopathy;Fuster;Am J Cardiol,1981
2. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer;Jensen;Semin Oncol,2006
3. Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer?;Kaklamani;Clin Breast Cancer,2003
4. Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy;van Dalen;Cochrane Database Syst Rev,2006
5. Comparative effects of paclitaxel and docetaxel on the metabolism and pharmacokinetics of epirubicin in breast cancer patients;Esposito;J Clin Oncol,1999
Cited by 123 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction;Nature Cardiovascular Research;2024-07-17
2. Characteristics and Clinical Outcomes of Patients Referred to a Cardio- Oncology Clinic: The First Lebanese Experience;2023-11-29
3. Comprehensive Evaluation of Cancer Treatment-Related Cardiac Dysfunction by Ultrasound Myocardial Strain: A Network Meta-Analysis;Cardiology in Review;2023-10-17
4. Euterpe oleracea extract (açaí) exhibits cardioprotective effects after chemotherapy treatment in a breast cancer model;BMC Complementary Medicine and Therapies;2023-08-25
5. Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors;International Journal of Cardiology;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3